Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited (India) holds 152 active US FDA Type II Drug Master Files and 14 inactive, has DMF or CEP filings on record for 40 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 3 FDA-registered manufacturing sites. 21 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Alembic Pharmaceuticals Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/alembic-pharmaceuticals-limited

Overview

Alembic Pharmaceuticals Limited is an Indian multinational pharmaceutical company primarily dealing in the manufacturing and marketing of pharmaceutical products and active pharmaceutical ingredients (APIs). The company is committed to research and development activities to innovate new medications and improve existing therapies.

Core services & business areas

Research and DevelopmentFormulation DevelopmentAPI ManufacturingPharmaceutical Manufacturing

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Alembic Pharmaceuticals Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Alembic Pharmaceuticals Limited holds 152 active (166 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • GLATIRAMER ACETATEActive2026-09-30
  • ABEMACICLIBActive2026-06-30
  • IPTACOPAN HYDROCHLORIDEActive2026-06-30
  • TEMAZEPAM USPActive2026-06-30
  • ADAPALENE USPActive2026-03-31
  • LINAGLIPTINActive2026-03-30
  • ARIPIPRAZOLE MONOHYDRATEActive2026-03-27
  • FLUPHENAZINE DECANOATE USPActive2026-03-25
  • TIRZEPATIDEActive2026-02-25
  • CILOSTAZOL USPActive2026-02-03
  • DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE USPActive2025-12-29
  • ENZALUTAMIDEActive2025-12-25
  • RUXOLITINIB PHOSPHATEActive2025-07-31
  • RIBOCICLIB SUCCINATEActive2025-03-31
  • AMANTADINE HYDROCHLORIDE USPActive2025-03-27
  • CABOZANTINIB-S-MALATEActive2025-03-27
  • SUVOREXANTActive2025-03-19
  • LEUPROLIDE ACETATE USPActive2025-02-24
  • RIFAXIMINActive2024-12-31
  • TRAMETINIBActive2024-09-29
  • VILOXAZINE HYDROCHLORIDEActive2024-05-31
  • TERIPARATIDEActive2023-09-29
  • PRUCALOPRIDE SUCCINATEActive2023-08-17
  • DAROLUTAMIDEActive2023-03-30
  • OCTREOTIDE ACETATE USPActive2022-12-30
  • NELARABINEActive2022-11-30
  • DEXLANSOPRAZOLEActive2022-10-20
  • NITROFURANTOIN MACROCRYSTAL USPActive2022-06-30
  • NITROFURANTOIN MONOHYDRATE USPActive2022-03-31
  • LAROTRECTINIB SULFATEActive2022-03-31
  • IVOSIDENIBActive2022-02-17
  • BINIMETINIBActive2021-12-30
  • PLERIXAFORActive2021-09-30
  • METHOTREXATE SODIUMActive2021-09-30
  • APALUTAMIDEActive2021-09-22
  • ACALABRUTINIBActive2021-06-30
  • CHLORDIAZEPOXIDE HYDROCHLORIDE USPActive2021-03-31
  • LINEZOLID USP (FORM-II)Active2021-02-23
  • FLUPHENAZINE HYDROCHLORIDE USPActive2020-12-30
  • THEOPHYLLINE (ANHYDROUS) USPActive2020-12-29
  • TEGASEROD MALEATEActive2020-11-30
  • CLOFARABINEActive2020-11-30
  • PENCICLOVIRActive2020-09-30
  • AZITHROMYCIN DIHYDRATE USP (ADF PROCESS)Active2020-07-31
  • ELVITEGRAVIRActive2020-03-30
  • LENALIDOMIDE (FORM-H1)Active2020-02-28
  • ICATIBANT ACETATEActive2020-02-06
  • VILAZODONE HYDROCHLORIDE (FORM-IV)Active2020-01-30
  • OBETICHOLIC ACIDActive2019-12-11
  • VENETOCLAXActive2019-11-20

Showing the 50 most relevant of 166 Drug Master Files (active first). The full list is in the FDA DMF list.

Excipient Drug Master Files

Alembic Pharmaceuticals Limited holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Alembic Pharmaceuticals Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

21 FDA enforcement records linked to this company.

  • recall — Class III2026-01-14

    Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

  • recall — Class III2025-11-26

    Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

  • recall — Class II2025-08-13

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

  • recall — Class II2025-06-18

    Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule

  • recall — Class II2025-06-04

    Failed Impurities/Degradation Specifications

  • 4832024-11-22

    Control procedures to monitor and validate performance

  • 4832024-11-22

    Test methods

  • 4832024-11-22

    Acceptance criteria for sampling & testing

  • 4832024-11-22

    Cleaning SOP/inspection

  • 4832024-11-22

    input/output verification

  • 4832024-03-08

    Review of representative number of batches

  • 4832024-03-08

    Scientifically sound laboratory controls

  • 4832024-03-08

    Storage under appropriate conditions

  • 4832024-03-08

    Written record of investigation incomplete

  • 4832023-03-24

    Quality control unit review of records

  • 4832023-03-24

    Approve or reject procedures or specs

  • recall — Class I2021-04-14

    Labeling: Label-mixup

  • recall — Class II2020-07-01

    Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.

  • 4832018-03-20

    Training--operations, GMPs, written procedures

  • 4832018-03-20

    Absence of Written Procedures

  • 4832018-03-20

    Investigations of discrepancies, failures

For suppliers

Is this Alembic Pharmaceuticals Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.